Study Stopped
Failed funding application.
DEMAND - DEgenerative Meniscal Tears - Arthroscopy vs. Dedicated Exercise
DEMAND
Randomised Controlled Trial Comparing Arthroscopy With Physiotherapy for Degenerative Meniscal Tears
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Patients with wear and tear in their knees (osteoarthritis) are often referred to orthopaedic surgeons following a sudden worsening of pain and mechanical symptoms (grinding, locking, giving way) in their knee due to tears of their meniscal cartilages. These tears are described as degenerative as they are not usually caused by a single injury but rather accumulation of wear and tear. It is not clear from the current available evidence what the best treatment for these patients is. Their underlying arthritis is not bad enough to require joint replacement yet and they were usually managing well with minimal problems from their knee until experiencing the meniscal tear. However, some of their symptoms are likely to be due to the arthritis rather than just the tear. Current treatment for these patients is usually in the form of conservative treatment with physiotherapy and supervised exercise or using arthroscopy (key-hole surgery) to trim the damaged area of the meniscus. We know from previous research that most of these patients will improve over time to some extent but it is not clear whether a greater improvement can be expected following surgery and if so, whether this applies to all patients with this problem or not. Our study is intended to compare the outcome of patients with proven degenerative meniscal tears imaged on MRI scans, when they are assigned to arthroscopy followed by supervised exercise or supervised exercise alone. They will be randomly assigned and the outcome will be assessed using patient-completed questionnaires (Knee Outcome Osteoarthritis and injury Score \[KOOS\], SF12, visual analogue score for pain) and whether the patients go on to require further surgery during the period of the trial. The patients will be assessed at baseline, at 6 weeks, 6 months, 12 months and 24 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2013
CompletedFirst Posted
Study publicly available on registry
April 14, 2014
CompletedStudy Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedSeptember 10, 2020
September 1, 2020
3 years
October 16, 2013
September 8, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Knee injury and Osteoarthritis Outcome Score
Patient completed outcome measure
6weeks, 6 months, 12 months, 24 months
Secondary Outcomes (2)
SF12
6 weeks, 6 months, 12 months, 24 months
Pain visual analogue score
6 weeks, 6 months, 12 months, 24 months
Study Arms (2)
Physiotherapy
ACTIVE COMPARATORPhysiotherapy
Arthroscopy
EXPERIMENTALArthroscopy
Interventions
Outpatient standardised physiotherapy regime with focus on exercise therapy
Eligibility Criteria
You may qualify if:
- Age over 45 years
- Knee pain in the presence of a medial meniscal tear on MRI.
You may not qualify if:
- History of trauma to the knee or ipsilateral lower limb in the past 2 years
- Inability to engage in postoperative rehabilitation
- Lacking capacity to consent
- Evidence of infection
- Previous knee surgery other than arthroscopy (diagnostic or partial meniscectomy) Neurological disease
- Inflammatory arthritis
- Loose bodies
- Ligament injuries causing symptomatic instability
- Women who are pregnant
- Have current signs or symptoms of severe, progressive or uncontrolled renal, hepatic, haematological, gastrointestinal, endocrine, pulmonary, cardiac, neurologic, or cerebral disease.
- Uncontrolled disease states, such as moderate/severe asthma, COPD or inflammatory bowel disease, where flares are commonly treated with oral or parenteral corticosteroids, or recurrent infections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Tyneside General Hospital
North Shields, Tyne and Wear, NE29 8NL, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialty Registrar
Study Record Dates
First Submitted
October 16, 2013
First Posted
April 14, 2014
Study Start
December 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
September 10, 2020
Record last verified: 2020-09